deltatrials
Completed PHASE1/PHASE2 INTERVENTIONAL NCT00006357

STI571 in Treating Patients With Recurrent or Refractory Soft Tissue Sarcoma

Dose Finding and Phase II Study of STI 571 in Advanced Soft Tissue Sarcoma

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Conditions Endometrial Cancer Gastrointestinal Stromal Tumor Ovarian Cancer Sarcoma Small Intestine Cancer
Interventions imatinib mesylate
Updated 5 times since 2017 Last updated: Sep 20, 2012 Started: Aug 31, 2000 Primary completion: Apr 30, 2001
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1/PHASE2 trial investigates Endometrial Cancer and Gastrointestinal Stromal Tumor and is currently completed. European Organisation for Research and Treatment of Cancer - EORTC leads this study, which shows 5 recorded versions since 2000 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 21 months · monthly snapshotCompleted

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE1/PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE1/PHASE2

    Phase: PHASE1_PHASE2 → PHASE1/PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE1_PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE1_PHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE1_PHASE2

    First recorded

Aug 2000

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • European Organisation for Research and Treatment of Cancer - EORTC
Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Aarhus, Denmark , Amsterdam, Netherlands , Copenhagen, Denmark , Edegem, Belgium , Groningen, Netherlands , Herlev, Denmark , Leiden, Netherlands , Leuven, Belgium , London, United Kingdom , Lyon, France and 6 more locations